Association between the soluble epoxide hydrolase gene and preeclampsia

References

• Choudhury M, Friedman JE. Epigenetics and microRNAs in preeclampsia. Clin Exp Hypertens. 2012;34:334–41. doi:10.3109/10641963.2011.649931.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592–94. doi:10.1126/science.1111726.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785–99. doi:10.1016/S0140-6736(05)71003-5.
   PubMed Web of Science ®Google Scholar
• Engender Health: Balancing the scales: Expanding treatment for pregnant women with life-threatening hypertensive conditions in developing countries. www.engenderhealth.org/files/pubs/maternal-health/EngenderHealth-Eclampsia-Report; Accessed 2017 Feb 2.
   Google Scholar
• Zoet GA, Koster MP, Velthuis BK, De Groot CJ, Maas AH, Fauser BC, et al. Determinants of future cardiovascular health in women with a history of preeclampsia. Maturitas. 2015;82:153–61. doi:10.1016/j.maturitas.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Gongora MC, Wenger NK. Cardiovascular complications of pregnancy. Int J Mol Sci. 2015;16:23905–28. doi:10.3390/ijms161023905.
   PubMed Web of Science ®Google Scholar
• Lee G, Tubby J. Preeclampsia and the risk of cardiovascular disease later in life–A review of the evidence. Midwifery. 2015;31:1127–34. doi:10.1016/j.midw.2015.09.005.
   PubMed Web of Science ®Google Scholar
• Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147–58. doi:10.1152/physiol.00043.2008.
   PubMed Web of Science ®Google Scholar
• Hermes W, Van Kesteren F, De Groot CJ. Preeclampsia and cardiovascular risk. Minerva Ginecol. 2012;64:281–92.
   PubMedGoogle Scholar
• VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in preeclampsia. Cardiovasc Res. 2000;47:38–48. doi:10.1016/S0008-6363(00)00087-0.
   PubMed Web of Science ®Google Scholar
• Gilbert JS, Ryan MJ, LaMarca BB, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–H550. doi:10.1152/ajpheart.01113.2007.
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;5789:373–76. doi:10.1038/288373a0.
   Web of Science ®Google Scholar
• Moncada S, Vane JR. The role of prostacyclin in vascular tissue. Fed Proc. 1979;38:66–71.
   PubMedGoogle Scholar
• Feletou M, Vanhoutte PM. Endothelium‐dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 1988;93:515–24. doi:10.1111/bph.1988.93.issue-3.
   PubMed Web of Science ®Google Scholar
• Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168–75. doi:10.1161/01.ATV.0000051384.43104.FC.
   PubMed Web of Science ®Google Scholar
• Yang L, Mäki‐Petäjä K, Cheriyan J, McEniery C, Wilkinson IB. The role of epoxyeicosatrienoic acids in the cardiovascular system. Br J Clin Pharmacol. 2015;80:28–44. doi:10.1111/bcp.12603.
   PubMed Web of Science ®Google Scholar
• Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;6752:493–97.
   Google Scholar
• Deng Y, Theken KN, Lee CR. Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol. 2010;48:331–41. doi:10.1016/j.yjmcc.2009.10.022.
   PubMed Web of Science ®Google Scholar
• Bellien J, Joannides R. Epoxyeicosatrienoic acid pathway in human health and diseases. J Cardiovasc Pharmacol. 2013;61:188–96. doi:10.1097/FJC.0b013e318273b007.
   PubMed Web of Science ®Google Scholar
• Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens. 2004;17:1192–200. doi:10.1016/j.amjhyper.2004.05.023.
   PubMed Web of Science ®Google Scholar
• Oltman CL, Weintraub NL, VanRollins M, Dellsperger KC. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res. 1998;83:932–39. doi:10.1161/01.RES.83.9.932.
   PubMed Web of Science ®Google Scholar
• Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 1996;28:703–11. doi:10.1097/00005344-199611000-00014.
   PubMed Web of Science ®Google Scholar
• Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 2012;92:101–30. doi:10.1152/physrev.00021.2011.
   PubMed Web of Science ®Google Scholar
• Wang D, DuBois RN. Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer. J Clin Invest. 2012;122:19–22. doi:10.1172/JCI61453.
   PubMed Web of Science ®Google Scholar
• Oni-Orisan A, Alsaleh N, Lee CR, Seubert JM. Epoxyeicosatrienoic acids and cardioprotection: the road to translation. J Mol Cell Cardiol. 2014;74:199–208. doi:10.1016/j.yjmcc.2014.05.016.
   PubMed Web of Science ®Google Scholar
• Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004;43:55–90. doi:10.1016/S0163-7827(03)00049-3.
   PubMed Web of Science ®Google Scholar
• Sinal CJ, Miyata M, Tohkin M, Nagata K, Bend JR, Gonzalez FJ. Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J Biol Chem. 2000;275:40504–10. doi:10.1074/jbc.M008106200.
   PubMed Web of Science ®Google Scholar
• Qiu H, Li N, Liu JY, Harris TR, Hammock BD, Chiamvimonvat N. Soluble epoxide hydrolase inhibitors and heart failure. Cardiovasc Ther. 2011;29:99–111. doi:10.1111/j.1755-5922.2010.00150.x.
   PubMed Web of Science ®Google Scholar
• Koerner IP, Jacks R, Grant DF, Koop D, Alkayed NJ. Polymorphisms in the human soluble epoxide hydrolase gene (EPHX2) linked to neuronal survival after ischemic injury. J Neurosurg Anesthesiol. 2006;18:316. doi:10.1097/00008506-200610000-00099.
   Google Scholar
• Merkel MJ, Liu L, Cao Z, Packwood W, Young J, Alkayed NJ, et al. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling. Am J Physiol Heart Circ Physiol. 2010;298:H679–H687. doi:10.1152/ajpheart.00533.2009.
   PubMed Web of Science ®Google Scholar
• Przybyla-Zawislak BD, Srivastava PK, Vázquez-Matías J, Mohrenweiser HW, Maxwell JE, Hammock BD, et al. Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol. 2003;64:482–90. doi:10.1124/mol.64.2.482.
   PubMed Web of Science ®Google Scholar
• Decker M, Arand M, Cronin A. Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol. 2009;83:297–318. doi:10.1007/s00204-009-0416-0.
   PubMed Web of Science ®Google Scholar
• Zordoky BNM, El-Kadi AOS. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases. Pharmacol Ther. 2010;125:446–63. doi:10.1016/j.pharmthera.2009.12.002.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Temellini A, Giuliani L, Rane A, Thomas H, Oesch F. Cytosolic epoxide hydrolase in humans: development and tissue distribution. Arch Toxicol. 1988;62:254–57. doi:10.1007/BF00332483.
   PubMed Web of Science ®Google Scholar
• Lee CR, Ke N, Ms B, Fornage M, Jm S, Jw N, et al. Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet. 2006;15:1640–49. doi:10.1093/hmg/ddl085.
   PubMed Web of Science ®Google Scholar
• Srivastava PK, Sharma VK, Kalonia DS, Grant DF. Polymorphisms in human soluble epoxide hydrolase: effects on enzyme activity, enzyme stability, and quaternary structure. Arch Biochem Biophys. 2004;427:164–69. doi:10.1016/j.abb.2004.05.003.
   PubMed Web of Science ®Google Scholar
• Fava C, Montagnana M, Danese E, Almgren P, Hedblad B, Engström G, et al. Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes. Pharmacogenet Genomics. 2010;20:94–103. doi:10.1097/FPC.0b013e3283349ec9.
   PubMed Web of Science ®Google Scholar
• Staff AC, Dechend R, Pijnenborg R. Learning from the placenta acute atherosis and vascular remodeling in preeclampsia–novel aspects for atherosclerosis and future cardiovascular health. Hypertension. 2010;56:1026–34. doi:10.1161/HYPERTENSIONAHA.110.157743.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Chang HH, Du J, Wang CY, Dong Z, Wang MH. Renal epoxyeicosatrienoic acid synthesis during pregnancy. Am J Physiol-Renal Physiol. 2005;288:F221–F226. doi:10.1152/ajprenal.00170.2004.
   PubMed Web of Science ®Google Scholar
• Catella F, Lawson JA, Fitzgerald DJ, FitzGerald GA. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci. 1990;87:5893–97. doi:10.1073/pnas.87.15.5893.
   PubMed Web of Science ®Google Scholar
• Zhang D, Ai D, Tanaka H, Hammock BD, Zhu Y. DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. BBA – Gene Regul Mech. 2010;1799:659–67. doi:10.1016/j.bbagrm.2010.09.006.
   Google Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122:1122.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res. 2007;35:e41. doi:10.1093/nar/gkm013.
   PubMed Web of Science ®Google Scholar
• Balic M, Pichler M, Strutz J, Heitzer E, Ausch C, Samonigg H, et al. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn. 2009;11:102–08. doi:10.2353/jmoldx.2009.080109.
   PubMed Web of Science ®Google Scholar
• Dahl C, Guldberg P. High-resolution melting for accurate assessment of DNA methylation. Clin Chem. 2007;53:1877–78. doi:10.1373/clinchem.2007.094854.
   PubMed Web of Science ®Google Scholar
• Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc. 2008;3:1903–08. doi:10.1038/nprot.2008.191.
   PubMed Web of Science ®Google Scholar
• Fleming I. Vascular cytochrome p450 enzymes: physiology and pathophys-iology. Trends Cardiovasc Med. 2008;18:20–25.
   Web of Science ®Google Scholar
• Node K, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase- derived eicosanoids. Science. 1999;285:1276–79. doi:10.1126/science.285.5431.1276.
   PubMed Web of Science ®Google Scholar
• Williams PJ, Pipkin FB. The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstetrics Gynaecol. 2011;25:405–17. doi:10.1016/j.bpobgyn.2011.02.007.
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565. doi:10.1136/bmj.38380.674340.E0.
   PubMed Web of Science ®Google Scholar
• Bianco A, Stone J, Lynch L, Lapinski R, Berkowitz G, Berkowitz RL. Pregnancy outcome at age 40 and older. Obstetrics Gynecol. 1996;87:917–22. doi:10.1016/0029-7844(96)00045-2.
   PubMed Web of Science ®Google Scholar
• Saftlas AF, Olson DR, Franks AL, Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990;163:460–65. doi:10.1016/0002-9378(90)91176-D.
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:1–22. doi:10.1067/mob.2000.107928.
   PubMed Web of Science ®Google Scholar
• England L, Zhang J. Smoking and risk of preeclampsia: a systematic review. Front Biosci. 2007;12:2471–83. doi:10.2741/2248.
   PubMed Web of Science ®Google Scholar
• Cincotta RB, Brennecke SP. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet. 1998;60:23–27. doi:10.1016/S0020-7292(97)00241-5.
   PubMed Web of Science ®Google Scholar
• Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990;97:762–69. doi:10.1111/j.1471-0528.1990.tb02569.x.
   PubMedGoogle Scholar
• Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K, Wong ND. Polymorphism of the soluble epoxide hydrolase is associated with Coronary Artery calcification in African-American subjects the Coronary Artery Risk Development In Young Adults (CARDIA) study. Circulation. 2004;109:335–39. doi:10.1161/01.CIR.0000109487.46725.02.
   PubMed Web of Science ®Google Scholar
• Lee CR, Pretorius M, Schuck RN, Burch LH, Bartlett J, Williams SM, et al. Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with forearm vasodilator responses in humans. Hypertension. 2011;57:116–22. doi:10.1161/HYPERTENSIONAHA.110.161695.
   PubMed Web of Science ®Google Scholar
• Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR, Siscovick DS, et al. Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis. 2007;190:26–34. doi:10.1016/j.atherosclerosis.2006.02.021.
   PubMed Web of Science ®Google Scholar
• Chen CW, Jaffe IZ, Karumanchi SA. Pre-eclampsia and cardiovascular disease. Cardiovasc Res. 2014;101:579–86. doi:10.1093/cvr/cvu018.
   PubMed Web of Science ®Google Scholar
• Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. Circulation. 2011;123:1243–62. doi:10.1161/CIR.0b013e31820faaf8.
   PubMed Web of Science ®Google Scholar
• Jiang H, McGiff JC, Fava C, Amen G, Nesta E, Zanconato G, et al. Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies. Am J Hypertens. 2013;26:271–8.
   Web of Science ®Google Scholar
• Revermann M, Schloss M, Barbosa-Sicard E, Mieth A, Liebner S, Morisseau C, et al. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 2010;30:909–14. doi:10.1161/ATVBAHA.110.204099.
   PubMed Web of Science ®Google Scholar
• Lee CR, Imig JD, Edin ML, Foley J, DeGraff LM, Bradbury JA, et al. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice. Faseb J. 2010;24:3770–81. doi:10.1096/fj.10-160119.
   PubMed Web of Science ®Google Scholar
• Koeners MP, Wesseling S, Ulu A, Sepúlveda RL, Morisseau C, Braam B, et al. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am J Physiol Endocrinol Metab. 2011;300:E691–E698. doi:10.1152/ajpendo.00710.2010.
   PubMed Web of Science ®Google Scholar
• Corenblum MJ, Wise VE, Georgi K, Hammock BD, Doris PA, Fornage M. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat. Hypertension. 2008;51:567–73. doi:10.1161/HYPERTENSIONAHA.107.102160.
   PubMed Web of Science ®Google Scholar
• Tain YL, Leu S, Wu KL, Lee WC, Chan JY. Melatonin prevents maternal fructose intake-induced programmed hypertension in the offspring: roles of nitric oxide and arachidonic acid metabolites. J Pineal Res. 2014;57:80–89. doi:10.1111/jpi.12145.
   PubMed Web of Science ®Google Scholar
• Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang C, et al. Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci. 2007;104:9018–23. doi:10.1073/pnas.0703229104.
   PubMed Web of Science ®Google Scholar
• Ai D, Pang W, Li N, Xu M, Jones PD, Yang J, et al. Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci. 2009;106:564–69. doi:10.1073/pnas.0811022106.
   PubMed Web of Science ®Google Scholar
• Jia RZ, Zhang X, Hu P, Liu XM, Hua XD, Wang X, et al. Screening for differential methylation status in human placenta in preeclampsia using a CpG island plus promoter microarray. Int J Mol Med. 2012;30:133.
   PubMed Web of Science ®Google Scholar
• Rusterholz C, Hahn S, Holzgreve W. Role of placentally produced inflammatory and regulatory cytokines in pregnancy ad the etiology of preeclampsia. Semin Immunopatol. 2007;29:151–62. doi:10.1007/s00281-007-0071-6.
   PubMed Web of Science ®Google Scholar